JAZZ reports Tuesday, Feb 23, 2027, after the close. After the last 4 reports the stock moved +7.1%, +4.0%, +7.7%, +13.2% the next day.
JAZZ is expected to report on Tuesday, Feb 23, 2027, after the close (US Eastern time).
| Report | EPS est. | EPS | Next day | Week |
|---|---|---|---|---|
| Nov 2, 2026 | -2.38 | -3.88 | +7.1% | +13.6% |
| Aug 3, 2026 | 6.18 | 5.71 | +4.0% | +2.0% |
| May 5, 2026 | 4.66 | 6.34 | +7.7% | +7.3% |
| Feb 24, 2026 | 6.51 | 6.64 | +13.2% | +7.4% |
| Nov 5, 2025 | 5.85 | 8.13 | −2.3% | −0.4% |
| Aug 5, 2025 | -6.25 | -8.25 | −6.4% | +0.1% |
| May 6, 2025 | 4.66 | 1.68 | −8.8% | −7.4% |
| Feb 25, 2025 | 5.81 | 6.60 | +3.2% | −0.5% |
Average move the next trading day over the last 8 reports: ±6.6% (5 of 8 up).
JAZZ is in an uptrend, momentum firm. $234.73 is the level overhead; $228.74 the first support below.
JAZZ at $230.26. Nearest resistance $234.73 (+1.9%). Nearest support $228.74 (−0.7%).
JAZZ chart, levels and analysis · Latest analysis: Jazz Pharmaceuticals (JAZZ) stock analysis, November 15, 2026: bullish medium‑conviction on upside breakout · Earnings this week
JAZZ is expected to report on Tuesday, Feb 23, 2027, after the close.
JAZZ reports after the close, US Eastern time.
After its report on Nov 2, 2026, JAZZ moved +7.1% the next trading day.
Over the last 8 reports, JAZZ moved 6.6% on average the next trading day, up 5 times out of 8.
Updated Nov 3, 2026 · Methodology · Research & education, not advice. Dates from company calendars via Yahoo Finance; moves from daily closes.
MarketCrew provides AI-generated market analysis and tools for informational and educational purposes only. Nothing here is investment advice or a recommendation to buy or sell any security, and it is not tailored to your circumstances. MarketCrew is not a registered investment adviser or broker-dealer. Markets involve risk, including the possible loss of principal — do your own research. © MarketCrew.